Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

Tina Marie Green, Ken H. Young, Carlo Visco, Zijun Y. Xu-Monette, Attilio Orazi, Ronald S. Go, Ole Nielsen, Ole V. Gadeberg, Torben Mourits-Andersen, Mikael Frederiksen, Lars Møller Pedersen, Michael Boe Møller

Research output: Contribution to journal › Article › peer-review

469 Scopus citations

Fingerprint

Dive into the research topics of 'Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone'. Together they form a unique fingerprint.

Medicine & Life Sciences